Redera, Ledelyn A.
HRN: 21-56-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2022
CEFUROXIME 1.5GM (VIAL)
06/20/2022
06/20/2022
IVT
1.5g
LD Only
Preoperative Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes